Kimberly-Clark to acquire Kenvue in $48.7 billion deal - CNBC
AI Summary1 min read
TL;DR
Kimberly-Clark is acquiring Kenvue, the parent company of Tylenol, in a multi-billion dollar deal to create a global health and wellness leader. The transaction values range from $40 billion to $48.7 billion across reports.
Tags
Kimberly-ClarkKenvueacquisitionhealth and wellnessTylenol
- Kimberly-Clark to acquire Kenvue in $48.7 billion deal CNBC
- Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal CNN
- Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader Yahoo Finance
- Kimberly-Clark to buy Kenvue in $48.7 billion deal Reuters
- Kimberly-Clark to Buy Tylenol Owner Kenvue in $40 Billion Deal Bloomberg